Research Article

Screening Potential Probiotic Characteristics of Lactobacillus brevis Strains In Vitro and Intervention Effect on Type I Diabetes In Vivo

Table 1

Experiments design of diabetic model mice.

Group TreatmentDose/ mouseTime of treatedMethods of delivered

(Cont)250 μL SalineDailyvia gavage
(STZ)180 mg/kgOne timesubcutaneously
(INS+STZ)100 μLDailysubcutaneously
(S1)250 μLDailyvia gavage
Male C57BL/6(S2)250 μLDailyvia gavage

(Cont), control group; (STZ), streptozotocin; (INS+STZ), insulin + streptozotocin; (S1), KLDS1.0727+ streptozotocin, and (S2), KLDS1.0373+ streptozotocin.